Clinical Trial

Effects of High-Frequency Chest Wall Oscillation Combined With Concurrent Training on Cough,in Cystic Fibrosis Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2026 (before its estimated May 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized clinical trial aims to evaluate the effects of high-frequency chest wall oscillation (HFCWO) combined with concurrent training on cough, sputum clearance, exercise tolerance, and respiratory muscle strength in patients with Cystic Fibrosis. A total of 24 participants meeting inclusion criteria will be randomly allocated into two groups: Group A will receive HFCWO plus concurrent training, while Group B will receive HFCWO alone for 8 weeks. Outcomes will be measured before and after intervention using the 6-minute walk test, spirometry, Leicester Cough Questionnaire, sputum volume, and the Cystic Fibrosis Questionnaire-Revised. The study will be conducted at Pulmonary Rehabilitation Unit, Gulab Devi Hospital and Mayo Hospital, Lahore. Statistical analysis will be performed using IBM SPSS Statistics, with significance set at p \< 0.05.
Trial Details
NCT Number NCT07519460
Lead Sponsor Riphah International University
Conditions Cystic Fibrosis
Enrollment 24 participants
Start Date 2026-04
Primary Completion 2026-05-28 (estimated)
Study Completion 2026-05-29 (estimated)
Updated on ClinicalTrials.gov 2026-04-09